v3.26.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses        
Research and development $ 34,496 $ 15,695 $ 69,226 $ 47,587
General and administrative 5,903 5,953 21,526 38,554
Total operating expenses 40,399 21,648 90,752 86,141
Operating loss (40,399) (21,648) (90,752) (86,141)
Other income and expense        
Gain on long-term investment 0 0 0 3,390
Other expense, net (9) (9) (16) (27)
Interest expense (12) (22) (43) (75)
Interest income 2,160 1,456 6,467 3,917
Amortization of premium on investments in U.S. Treasury securities, net (40) (60) (19) (106)
Total other income and expense 2,099 1,365 6,389 7,099
Loss from operations before income taxes (38,300) (20,283) (84,363) (79,042)
Net loss (38,300) (20,283) (84,363) (79,042)
Net unrealized gain (loss) on investments in U.S. Treasury securities (167) 102 (653) 192
Total other comprehensive gain (loss) (167) 102 (653) 192
Comprehensive loss $ (38,467) $ (20,181) $ (85,016) $ (78,850)
Net loss per common share, basic $ (0.43) $ (0.33) $ (0.99) $ (1.72)
Net loss per common share, diluted $ (0.43) $ (0.33) $ (0.99) $ (1.72)
Weighted-average number of shares outstanding used in computation of net loss per common share, basic 88,681,360 60,980,867 85,191,438 45,991,572
Weighted-average number of shares outstanding used in computation of net loss per common share,diluted 88,681,360 60,980,867 85,191,438 45,991,572